Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
63.34 USD | +2.60% | +25.92% | +19.28% |
06:22pm | Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating | MT |
May. 08 | Sector Update: Health Care Stocks Slipping Wednesday Afternoon | MT |
Financials (USD)
Sales 2024 * | 2.47B | Sales 2025 * | 2.66B | Capitalization | 8.34B |
---|---|---|---|---|---|
Net income 2024 * | 182M | Net income 2025 * | 394M | EV / Sales 2024 * | 2.99 x |
Net cash position 2024 * | 939M | Net cash position 2025 * | 1.44B | EV / Sales 2025 * | 2.59 x |
P/E ratio 2024 * |
46.3
x | P/E ratio 2025 * |
22.3
x | Employees | 5,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.72% |
Latest transcript on Globus Medical, Inc.
1 day | +2.64% | ||
1 week | +25.92% | ||
Current month | +27.67% | ||
1 month | +18.41% | ||
3 months | +21.40% | ||
6 months | +44.83% | ||
Current year | +19.28% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | 15-05-03 |
David Davidar
FOU | Founder | 58 | 03-02-28 |
David Paul
FOU | Founder | 57 | 03-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Zarrilli
BRD | Director/Board Member | 62 | 19-04-30 |
Rob Douglas
BRD | Director/Board Member | 64 | 19-12-10 |
James Tobin
BRD | Director/Board Member | 79 | 15-08-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.01% | 0 M€ | +8.89% | ||
0.99% | 0 M€ | +2.09% | - | |
0.74% | 0 M€ | -5.02% | ||
0.44% | 0 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 63.59 | +3.01% | 1 193 277 |
24-05-08 | 61.73 | +20.19% | 6,662,790 |
24-05-07 | 51.36 | +2.17% | 1,831,092 |
24-05-06 | 50.27 | -3.23% | 1,755,937 |
24-05-03 | 51.95 | +2.91% | 1,061,977 |
Delayed Quote Nyse, May 09, 2024 at 02:43 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.28% | 8.34B | |
-4.83% | 183B | |
+0.10% | 108B | |
-3.74% | 67.51B | |
+3.71% | 50.67B | |
+9.04% | 44.7B | |
+2.41% | 40.95B | |
+6.44% | 26.8B | |
+3.46% | 26.71B | |
+12.66% | 24.62B |
- Stock Market
- Equities
- GMED Stock